Disclosures for "ZSCAN1 Antibodies in Pediatric and Adult Patients With Non-Paraneoplastic ROHHAD Syndrome "
-
Dr. Olivé has nothing to disclose.
-
Miss Serafim has received research support from Fundação para as ciências e tecnologia.
-
Dr. Simabukuro has nothing to disclose.
-
Dr. Ortega-González has nothing to disclose.
-
Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
-
The institution of Dr. Weese-Mayer has received research support from NIH. The institution of Dr. Weese-Mayer has received research support from FDA.
-
Mr. Rand has nothing to disclose.
-
Dr. Fons has nothing to disclose.
-
Dr. Fernández Ramos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
-
Dr. Fonseca has nothing to disclose.
-
Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DEXCOM. Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVONORDISK. Dr. Clemente has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AIRLIQUIDE.
-
Dr. Leão has nothing to disclose.
-
Dr. Ibanez-Mico has nothing to disclose.
-
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
-
Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
-
The institution of Dr. Sabater has received research support from Instituto de Salud Carlos III.